Lutetium-177 PSMA for Patients with Advanced Stage Prostate Cancer
What is Lutetium PSMA therapy? Lutetium-177 PSMA (prostate-specific membrane antigen) is a radionuclide therapy which aims to destroy prostate cancer cells that have spread to
What is Lutetium PSMA therapy? Lutetium-177 PSMA (prostate-specific membrane antigen) is a radionuclide therapy which aims to destroy prostate cancer cells that have spread to
Neolife’s patient-centered approach and quality have made it a trusted name in oncology abroad with the opening of six new centers in Europe.